b'Appendices Appendix 4 GENOME CANADA Notes to Financial Statements (continued)Year ended March 31, 2019 (in thousands of dollars) 8.Employee pension plan: The Corporation maintains, for the benefit of almost all of its employees, a defined contribution pension plan. The cost of the plan is recorded in the statement of operations and changes in net assets as it is incurred. The charge for the year totals $201 (2018 - $195).9.Supplemental cash flow information:20192018Gain (loss) on disposal of investments$17$(184) Amount transferred to capital assets(9) Fair value adjustment7849$86$(135)10. Commitments: Committed funding: The Corporation is committed to finance approved research projects, science and technology platforms and Genome Centre operations in accordance with established agreements.As at March 31, 2019, the payments committed are approximately $64,704 in 2020 and $42,059 for other future years. Operating leases: The Corporation leases its premises and equipment under long-term operating leases, which expire at various dates between 2020 and 2028.The minimum aggregate lease payments are approximately as follows: 2020$100 202199 202296 2023100 2024 and thereafter558$95312 12'